Shopping Cart
- Remove All
- Your shopping cart is currently empty
CYP11B1-IN-2 (compound 7aa) is a selective, orally active inhibitor of CYP11B1 with an IC50 of 9 nM for human CYP11B1 and 25 nM for rat CYP11B1. It can be used to study diseases caused by cortisol overload.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 10-14 weeks | |
50 mg | $1,980 | 10-14 weeks | |
100 mg | $2,500 | 10-14 weeks |
Description | CYP11B1-IN-2 (compound 7aa) is a selective, orally active inhibitor of CYP11B1 with an IC50 of 9 nM for human CYP11B1 and 25 nM for rat CYP11B1. It can be used to study diseases caused by cortisol overload. |
Targets&IC50 | CYP2C19:>10 μM, CYP11B2:1121 ± 237 nM, CYP11B1:25 nM (rat CYP11B1), CYP3A4:>10 μM, CYP11B1:9 ± 2 nM (human CYP11B1), CYP2D6:>10 μM, CYP2E1:>10 μM, CYP1A2:>10 μM, CYP2C9:>10 μM |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.